Dana B. Sparks

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Roy S. Herbst, David R. Gandara, Fred R. Hirsch et al. · Clinical Cancer Research · 2015 · 240 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Participatory design of a collaborative clinical trial protocol writing system

Chunhua Weng, David W. McDonald, Dana B. Sparks et al. · International Journal of Medical Informatics · 2006 · 42 citations

Medicine, Biomedical Informatics, Health Informatics +12

Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG Intergroup study

David S. Alberts, P. Y. Liu, Edward V. Hannigan et al. · International Journal of Gynecological Cancer · 1996 · 30 citations

Medicine, Gynecology, Oncology +15

SWOG S1007: A phase III, randomized clinical trial of standard adjuvant endocrine therapy with or without chemotherapy in patients with one to three positive nodes, hormone receptor (HR)-positive, and HER2-negative breast cancer with recurrence score (RS) of 25 or less.

Ana M. González-Angulo, WE Barlow, JR Gralow et al. · Journal of Clinical Oncology · 2011 · 27 citations

Medicine, Oncology, Breast Oncology +15

National impact of the COVID-19 pandemic on clinical trial staff attrition: Results of the SWOG Cancer Research Network Survey of Oncology Research Professionals.

Don S. Dizon, Connie M. Szczepanek, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2022 · 12 citations

Medicine, Oncology, Cancer Control +7